PR Newswire | Sep 20, 2021 07:01AM EDT

September 2021

09/20 06:00 CDT

Enveric Biosciences to Participate in Upcoming Investor Conferences in September 2021 NAPLES, Fla., Sept. 20, 2021

NAPLES, Fla., Sept. 20, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform for the mind and body using psychedelics and cannabinoids, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming investor conferences:

Maxim's Advances in Mental Health Virtual ConferenceWednesday, September 22nd at 10:00 a.m. ETPanel titled: Next Gen Psychedelics: Novel Chemical EntitiesTo attend, register here

Benzinga's Healthcare Small Cap Virtual ConferenceThursday, September 30th at 3:40 p.m. ETTo attend, register here

For more information about the conferences, or to schedule a one-on-one meeting with Enveric's management, please contact your appropriate representative directly, or send an email to Maxim at jthompson@maximgrp.com, Benzinga at VIPevents@benzinga.com, or KCSA Strategic Communications at EnvericBio@kcsa.com.

About Enveric BiosciencesEnveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For more information, please visit www.enveric.com.

Investor ContactsValter Pinto / Allison SossKCSA Strategic Communications212.896.1254 / 212.896.1267valter@kcsa.com / asoss@kcsa.com

Media ContactsCaitlin Kasunich / Raquel ConaKCSA Strategic Communications212.896.1241 / 212.896.1204ckasunich@kcsa.com / rcona@kcsa.com

View original content: https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-september-2021-301380168.html

SOURCE Enveric Biosciences